Your browser doesn't support javascript.
loading
Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme.
Ashraf, Haseem; Saghir, Zaigham; Dirksen, Asger; Pedersen, Jesper Holst; Thomsen, Laura Hohwü; Døssing, Martin; Tønnesen, Philip.
Afiliação
  • Ashraf H; Department of Respiratory Medicine, Gentofte University Hospital, Hellerup, Denmark Department of Radiology, Akershus University Hospital, Lørenskog, Norway.
  • Saghir Z; Department of Respiratory Medicine, Gentofte University Hospital, Hellerup, Denmark.
  • Dirksen A; Department of Respiratory Medicine, Gentofte University Hospital, Hellerup, Denmark.
  • Pedersen JH; Department of Thoracic Surgery RT, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Thomsen LH; Department of Respiratory Medicine, Gentofte University Hospital, Hellerup, Denmark.
  • Døssing M; Department of Internal Medicine, Frederikssund Hospital, Frederikssund, Denmark.
  • Tønnesen P; Department of Respiratory Medicine, Gentofte University Hospital, Hellerup, Denmark.
Thorax ; 69(6): 574-9, 2014 Jun.
Article em En | MEDLINE | ID: mdl-24443174
ABSTRACT

BACKGROUND:

We present the final results of the effect of lung cancer screening with low-dose CT on the smoking habits of participants in a 5-year screening trial.

METHODS:

The Danish Lung Cancer Screening Trial (DLCST) was a 5-year screening trial that enrolled 4104 subjects; 2052 were randomised to annual low-dose CT (CT group) and 2052 received no intervention (control group). Participants were current and ex-smokers (≥4 weeks abstinence from smoking) with a tobacco consumption of ≥20 pack years. Smoking habits were determined annually. Missing values for smoking status at the final screening round were handled using two different models.

RESULTS:

There were no statistically significant differences in annual smoking status between the CT group and control group. Overall the ex-smoker rates (CT + control group) significantly increased from 24% (baseline) to 37% at year 5 of screening (p<0.001). The annual point prevalence quit rate increased from 11% to 24% during the five screening rounds; the ex-smokers' relapse rate remained stable, around 11%, across the same period.

CONCLUSIONS:

Screening with low-dose CT had no extra effect on smoking status compared with the control group, but overall the screening programme probably promoted smoking cessation. CLINICAL TRIAL REGISTRATION The DLCST is registered in Clinical Trials.gov Protocol Registration System (identification no. NCT00496977).
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fumar / Abandono do Hábito de Fumar / Detecção Precoce de Câncer / Neoplasias Pulmonares / Motivação Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prevalence_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Thorax Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fumar / Abandono do Hábito de Fumar / Detecção Precoce de Câncer / Neoplasias Pulmonares / Motivação Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prevalence_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Thorax Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Noruega